Reshma Kewalramani
CEO, President at Vertex Pharmaceuticals Inc / Ma (VRTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $19.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 3SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 400 | $479.75 | $192K | +5.0% |
| Mar 3SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 120 | $481.50 | $58K | +4.6% |
| Mar 3SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 240 | $482.84 | $116K | +4.3% |
| Mar 3SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 2,510 | $487.13 | $1.2M | +3.4% |
| Mar 3SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 3,278 | $488.27 | $1.6M | +3.1% |
| Mar 3SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 460 | $489.32 | $225K | +2.9% |
| Mar 3SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 2,725 | $490.54 | $1.3M | +2.6% |
| Mar 3SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 949 | $491.30 | $466K | +2.5% |
| Mar 3SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 2,520 | $493.29 | $1.2M | +2.1% |
| Mar 3SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 3,498 | $494.33 | $1.7M | +1.9% |
| Mar 3SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 15,580 | $495.38 | $7.7M | +1.6% |
| Mar 3SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 5,995 | $496.16 | $3.0M | +1.5% |
| Mar 3SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 1,725 | $496.95 | $857K | +1.3% |
- Sell
CEO, President Reshma Kewalramani sold $192K of VRTX at $479.75 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Reshma Kewalramani sold $58K of VRTX at $481.50 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Reshma Kewalramani sold $116K of VRTX at $482.84 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Reshma Kewalramani sold $1.2M of VRTX at $487.13 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Reshma Kewalramani sold $1.6M of VRTX at $488.27 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Reshma Kewalramani sold $225K of VRTX at $489.32 — pre-scheduled 10b5-1 plan sale.